Cargando…
Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India
BACKGROUND AND PURPOSE: The main cause of death in COVID-19 pneumonia is acute respiratory distress syndrome which is preceded by massive cytokine release. Low-dose radiation therapy (LDRT) has anti-inflammatory and immunomodulatory effects that can interfere with the inflammatory cascade, reducing...
Autores principales: | Ganesan, Govindaraj, Ponniah, Sasipriya, Sundaram, Vivek, Marimuthu, Praveen Kumar, Pitchaikannu, Venkatraman, Chandrasekaran, Manigandan, Thangarasu, Janakiraman, Kannupaiyan, Gunasekaran, Ramamoorthy, Prabhu, Thangaraj, Brindha, Shree Vaishnavi, Raguram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359565/ https://www.ncbi.nlm.nih.gov/pubmed/34391759 http://dx.doi.org/10.1016/j.radonc.2021.08.001 |
Ejemplares similares
-
Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India”
por: Ganesan, Govindaraj, et al.
Publicado: (2022) -
Response to “Comments on whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)”
por: Ganesan, Govindaraj, et al.
Publicado: (2022) -
Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)
por: Ganesan, Govindaraj, et al.
Publicado: (2022) -
Tuberculous Otitis Media and Staphylococcus aureus Coinfection in a Five-Year-Old Boy with Miliary Tuberculosis
por: Manigandan, Gopalakrishnan, et al.
Publicado: (2013) -
Assessing the legal duty to use or disclose interim data for ongoing clinical trials
por: Eckstein, Lisa
Publicado: (2019)